Anti-EGFR antibodies and antibody drug conjugates
US9493568B2 · kind B2 · utility
9Cited by
9References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 20, 2015 |
| Grant date | Nov 15, 2016 |
| Priority date | — |
| Expiry date | Mar 20, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to anti-epidermal growth factor (EGFR) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.